Table 13.
Treatment | Epithelization period in days | Percentage reduction in period epithelization |
---|---|---|
Simple ointment | 18.67 ± 0.33 | 0.00 |
Aqueous fraction 5% (w/w) ointment | 13.67 ± 0.21adefg(3) | 26.78 |
Aqueous fraction 10% (w/w) ointment | 13.50 ± 0.34adefg(3) | 27.69 |
Chloroform fraction 5% (w/w) ointment | 15.83 ± 0.40abch(3)fg(1) | 15.21 |
Chloroform fraction 10% (w/w) ointment | 15.67 ± 0.33abch(3)f2g1 | 16.07 |
Hexane fraction 5% (w/w) ointment | 17.33 ± 0.21ad(1)bch(3)e2 | 7.18 |
Hexane fraction 10% (w/w) ointment | 17.17 ± 0.17ade(1)bch(3) | 8.03 |
Nitrofurazone 0.2% (w/v) ointment | 13.50 ± 0.22adefg(3) | 27.69 |
Data are expressed as mean ± SEM; n = 6; a, compared with simple ointment; b, compared with 5% aqueous fraction; c, compared with 10% aqueous fraction; d, compared with 5% chloroform fraction; e, compared with 10% chloroform fraction; f, compared with 5% hexane fraction; g, compared with 10% hexane fraction; h, compared with nitrofurazone 0.2% ointment; 1, p < 0.05; 2, p < 0.01; 3, p < 0.001.